{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T06:43:26Z","timestamp":1784270606057,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.antiviral.2012.06.006","type":"journal-article","created":{"date-parts":[[2012,6,26]],"date-time":"2012-06-26T19:23:24Z","timestamp":1340738604000},"page":"193-201","source":"Crossref","is-referenced-by-count":41,"title":["Rhinovirus infections and immunisation induce cross-serotype reactive antibodies to VP1"],"prefix":"10.1016","volume":"95","author":[{"given":"Gary R.","family":"McLean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross P.","family":"Walton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasren","family":"Paktiawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Kebadze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Gogsadze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Niespodziana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Valenta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan W.","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian L.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2012.06.006_b0010","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0166-0934(87)90048-6","article-title":"An ELISA for the detection of rhinovirus specific antibody in serum and nasal secretion","volume":"15","author":"Barclay","year":"1987","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.antiviral.2012.06.006_b0020","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/jmv.1890250411","article-title":"Evaluation of an enzyme-linked immunosorbent assay that measures rhinovirus-specific antibodies in human sera and nasal secretions","volume":"25","author":"Barclay","year":"1988","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2012.06.006_b0015","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1017\/S095026880003106X","article-title":"The time course of the humoral immune response to rhinovirus infection","volume":"103","author":"Barclay","year":"1989","journal-title":"Epidemiol. Infect."},{"issue":"Pt 7","key":"10.1016\/j.antiviral.2012.06.006_b0030","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1099\/0022-1317-74-7-1295","article-title":"Characterization of monoclonal antibodies raised against a synthetic peptide capable of inducing a neutralizing response to human rhinovirus type 2","volume":"74","author":"Barnett","year":"1993","journal-title":"J. Gen. Virol."},{"issue":"Pt 5","key":"10.1016\/j.antiviral.2012.06.006_b0025","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1099\/0022-1317-76-5-1255","article-title":"Monoclonal antibodies to a peptide of human rhinovirus type 2 with different specificities recognize the same minimum sequence","volume":"76","author":"Barnett","year":"1995","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2012.06.006_b0035","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nm1713","article-title":"Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation","volume":"14","author":"Bartlett","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2012.06.006_b0040","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/jmv.1890360404","article-title":"The specificity of antibodies induced by infection with rhinovirus type 2","volume":"36","author":"Carey","year":"1992","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2012.06.006_b0045","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4049\/jimmunol.100.1.107","article-title":"Rhinoviruses: Basis for a numbering system. 1. HeLa cells for propagationand serologic procedures","volume":"100","author":"Conant","year":"1968","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2012.06.006_b0050","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4049\/jimmunol.100.1.114","article-title":"Rhinoviruses: Basis for a numbering system. II. Serologic characterization of prototype strains","volume":"100","author":"Conant","year":"1968","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2012.06.006_b0055","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1084\/jem.165.1.64","article-title":"IgG2a restriction of murine antibodies elicited by viral infections","volume":"165","author":"Coutelier","year":"1987","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2012.06.006_b0060","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4049\/jimmunol.99.2.297","article-title":"Rhinovirus neutralizing antibody in tears, parotid saliva, nasal secretions and serum","volume":"99","author":"Douglas","year":"1967","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2012.06.006_b0065","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.4049\/jimmunol.0713622","article-title":"A combination vaccine for allergy and rhinovirus infections based on rhinovirus-derived surface protein VP1 and a nonallergenic peptide of the major timothy grass pollen allergen Phl p 1","volume":"182","author":"Edlmayr","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2012.06.006_b0070","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1183\/09031936.00149109","article-title":"Antibodies induced with recombinant VP1 from human rhinovirus exhibit cross-neutralisation","volume":"37","author":"Edlmayr","year":"2011","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.antiviral.2012.06.006_b0075","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/oxfordjournals.aje.a112233","article-title":"Is a rhinovirus vaccine possible?","volume":"103","author":"Fox","year":"1976","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.antiviral.2012.06.006_b0080","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1055\/s-2007-976490","article-title":"Rhinovirus and coronavirus infections","volume":"28","author":"Greenberg","year":"2007","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.antiviral.2012.06.006_b0085","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/0092-8674(89)90688-0","article-title":"The major human rhinovirus receptor is ICAM-1","volume":"56","author":"Greve","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2012.06.006_b0090","first-page":"265","article-title":"Virology and immunology of the common cold","volume":"23","author":"Gwaltney","year":"1985","journal-title":"Rhinol."},{"key":"10.1016\/j.antiviral.2012.06.006_b0095","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1073\/pnas.91.5.1839","article-title":"Members of the low density lipoprotein receptor family mediate cell entry of a minor-group common cold virus","volume":"91","author":"Hofer","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.antiviral.2012.06.006_b0100","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1164\/rccm.200802-309OC","article-title":"Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children","volume":"178","author":"Jackson","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.antiviral.2012.06.006_b0110","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1136\/bmj.310.6989.1225","article-title":"Community study of role of viral infections in exacerbations of asthma in 9\u201311 year old children","volume":"310","author":"Johnston","year":"1995","journal-title":"Bmj"},{"key":"10.1016\/j.antiviral.2012.06.006_b0105","doi-asserted-by":"crossref","first-page":"6172","DOI":"10.4049\/jimmunol.160.12.6172","article-title":"Low grade rhinovirus infection induces a prolonged release of IL-8 in pulmonary epithelium","volume":"160","author":"Johnston","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2012.06.006_b0115","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jaci.2010.04.016","article-title":"Recurrent and persistent respiratory tract viral infections in patients with primary hypogammaglobulinemia","volume":"126","author":"Kainulainen","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.antiviral.2012.06.006_b0120","doi-asserted-by":"crossref","first-page":"7040","DOI":"10.1128\/JVI.00557-09","article-title":"Antibodies to the buried N terminus of rhinovirus VP4 exhibit cross-serotypic neutralization","volume":"83","author":"Katpally","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.06.006_b0125","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4049\/jimmunol.104.3.566","article-title":"Analysis of the neutralizing activity in nasal wash and serum following intranasal vaccinaion with inactivated type 13 rhinovirus","volume":"104","author":"Knopf","year":"1970","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2012.06.006_b0130","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1146\/annurev.immunol.20.100301.064842","article-title":"CpG motifs in bacterial DNA and their immune effects","volume":"20","author":"Krieg","year":"2002","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2012.06.006_b0135","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1099\/vir.0.81137-0","article-title":"Alignment of capsid protein VP1 sequences of all human rhinovirus prototype strains: conserved motifs and functional domains","volume":"87","author":"Laine","year":"2006","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2012.06.006_b0140","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1128\/JVI.78.7.3663-3674.2004","article-title":"VP1 sequencing of all human rhinovirus serotypes: insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds","volume":"78","author":"Ledford","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.06.006_b0145","doi-asserted-by":"crossref","first-page":"6774","DOI":"10.1073\/pnas.95.12.6774","article-title":"Antiviral agent blocks breathing of the common cold virus","volume":"95","author":"Lewis","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.antiviral.2012.06.006_b0150","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/thx.2005.042523","article-title":"Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children","volume":"61","author":"Murray","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.antiviral.2012.06.006_b0155","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/eji.1830111212","article-title":"Activation of mouse complement by monoclonal mouse antibodies","volume":"11","author":"Neuberger","year":"1981","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.antiviral.2012.06.006_b0160","first-page":"25","article-title":"Misdirected antibody responses against an N-terminal epitope on human rhinovirus VP1 as explanation for recurrent RV infections","volume":"25","author":"Niespodziana","year":"2011","journal-title":"Faseb. J."},{"key":"10.1016\/j.antiviral.2012.06.006_b0165","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/oxfordjournals.aje.a121076","article-title":"Evidence for protective effect of an inactivated rhinovirus vaccine administered by the nasal route","volume":"90","author":"Perkins","year":"1969","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.antiviral.2012.06.006_b0170","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.4049\/jimmunol.173.3.1978","article-title":"Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract","volume":"173","author":"Renegar","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2012.06.006_b0005","doi-asserted-by":"crossref","unstructured":"Rhinoviruses: a numbering system., 1967. Nature 213, 761\u2013762.","DOI":"10.1038\/213761a0"},{"key":"10.1016\/j.antiviral.2012.06.006_b0175","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/317145a0","article-title":"Structure of a human common cold virus and functional relationship to other picornaviruses","volume":"317","author":"Rossmann","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2012.06.006_b0180","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3181\/00379727-147-38383","article-title":"Rhinoviruses: an antigenic study of the prototype virus strains","volume":"147","author":"Schieble","year":"1974","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.antiviral.2012.06.006_b0185","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1128\/JVI.57.1.246-257.1986","article-title":"Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14","volume":"57","author":"Sherry","year":"1986","journal-title":"J. Virol."},{"issue":"Pt 2","key":"10.1016\/j.antiviral.2012.06.006_b0190","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1099\/0022-1317-68-2-315","article-title":"A neutralizing epitope on human rhinovirus type 2 includes amino acid residues between 153 and 164 of virus capsid protein VP2","volume":"68","author":"Skern","year":"1987","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2012.06.006_b0195","first-page":"285","article-title":"Rhinovirus neutralizing antibody responses and their measurement","volume":"78","author":"Taylor-Robinson","year":"1963","journal-title":"Am. J. Hyg."},{"key":"10.1016\/j.antiviral.2012.06.006_b0200","doi-asserted-by":"crossref","unstructured":"Turner, R.B., 1997. Epidemiology, pathogenesis, and treatment of the common cold. Ann Allergy Asthma Immunol. 78, 531\u2013539; quiz 539\u2013540.","DOI":"10.1016\/S1081-1206(10)63213-9"},{"key":"10.1016\/j.antiviral.2012.06.006_b0205","doi-asserted-by":"crossref","first-page":"6923","DOI":"10.1128\/JVI.77.12.6923-6930.2003","article-title":"Sequence and structure of human rhinoviruses reveal the basis of receptor discrimination","volume":"77","author":"Vlasak","year":"2003","journal-title":"J. Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354212001477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354212001477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T22:19:25Z","timestamp":1687558765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354212001477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0166354212001477"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2012.06.006","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}